Boehringer Ingelheim has signed a three-year agreement with the US startup for its Seqster operating system (SeqsterOS) and Digital Front Door platform, a portal that gathers together a patient's ...
Boehringer Ingelheim (BI) and Salipro Biotech have entered into a partnership aimed at accelerating the development of ...
Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...
The One Medicine Platform replaces 20+ legacy platforms—unifying medicinal development processes & data sources into a ...
The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable ...
A spinout from the University of Oxford, Brainomix now operates in more than 20 countries globally, including the US. It has pioneered the development of an AI platform, Brainomix 360 Stroke, that ...
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...
GlobalData on MSN29d
Boehringer and partners commence gene therapy trial for cystic fibrosisBoehringer Ingelheim, the UK Respiratory Gene Therapy ... efficacy and safety in this particular patient group. It is ...
Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered ...
Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback